Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae-Reference-Cited by-同舟云学术

Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae

Published:2017-12 Issue:4 Volume:89 Page:328-333
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Bork Jacqueline T.^ORCID,Heil Emily L.,Leekha Surbhi,Fowler Randal C.,Hanson Nancy D.,Majumdar Anjali,Johnson J. Kristie

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference27 articles.

1. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas Aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen;Carmeli;Lancet Infect Dis,2016

2. Prevalence of beta-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY antimicrobial surveillance program (2010);Castanheira;Antimicrob Agents Chemother,2013

3. Development of a Luminex xTAG(R) assay for cost-effective multiplex deteccion of B-lactamases in gram-negative bacteria;Ceyssens;J Antimicrob Chemother,2016

4. Impact of Cefepime therapy on mortality among patients with bloodstream infections caused by extended-Spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli;Chopra;Antimicrob Agents Chemother,2012

5. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. M100-S24. Vol. 32;Clinical and Laboratory Standards Institute (CLSI),2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study;International Journal of Infectious Diseases;2023-09

2. Cefepime for Ceftriaxone-Resistant Enterobacterales With Chromosomal AmpC β-Lactamases;Clinical Infectious Diseases;2023-03-28

3. Digital microbiology;Clinical Microbiology and Infection;2020-10

4. Prevalence of susceptibility patterns of opportunistic bacteria in line with CLSI or EUCAST among Haemophilus parainfluenzae isolated from respiratory microbiota;Scientific Reports;2020-07-13

5. Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms;European Journal of Clinical Microbiology & Infectious Diseases;2019-11-02